IBACR — IB Acquisition Corp.

—
Nasdaq · Health Care · Life Sciences Tools & Services · CIK 1998781 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 0 -624,429 -567,166 8,518,014 30,161 2,447,413
Mar 2026 0 0 -748,177 -639,866 8,477,425 4,634 1,839,658
Dec 2025 0 0 -180,000 -58,902 16,405,261 165,484 1,162,171
Jun 2025 1,254,202 0 -172,210 818,610 122,176,971 486,018 549,009

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Sep 2025 0 -748,908 3,416,169 17,134,092 1,832,100 15,301,992 —
Sep 2024 0 -523,974 1,867,387 119,800,388 722,230 119,078,158 —

TTM Snapshot

Revenues TTM
$-3,875,873
NetIncome TTM
$-399,569
OpCashFlow TTM
—
Assets (Latest)
$8,518,014
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
IDXX IDEXX LABORATORIES INC /DE $54.38B $690.24 —
IQV IQVIA HOLDINGS INC. $42.45B $257.60 —
INCY INCYTE CORP $24.27B $119.09 —
MEDP Medpace Holdings, Inc. $18.27B $653.09 —
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. $15.92B $332.16 —

News headlines (Yahoo Finance, 1h cache)

IB Acquisition Corp. Announces Date of 2026 Annual Meeting of Stockholders
2026-10-15 20:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.